# Bioavailability of the Fixed Combination of Amodiaquine and Artesunate Under Fed & Fasted Conditions

> **NCT00386503** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 22 (—)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Artesunate + Amodiaquine

## Key facts

- **NCT ID:** NCT00386503
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2006-12
- **Final completion:** —
- **Target enrollment:** 22 (—)
- **Last updated:** 2008-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00386503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00386503, "Bioavailability of the Fixed Combination of Amodiaquine and Artesunate Under Fed & Fasted Conditions". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00386503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*